These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

535 related items for PubMed ID: 15370626

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Granisetron: an update on its clinical use in the management of nausea and vomiting.
    Aapro M.
    Oncologist; 2004; 9(6):673-86. PubMed ID: 15561811
    [Abstract] [Full Text] [Related]

  • 5. 5-HT3-receptor antagonists in the control of delayed-onset emesis.
    Gridelli C.
    Anticancer Res; 2003; 23(3C):2773-82. PubMed ID: 12926112
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Current treatment patterns for radiation-induced nausea and vomiting.
    Kinay M.
    Acta Oncol; 2004 Sep; 43 Suppl 15():9-12. PubMed ID: 15370624
    [No Abstract] [Full Text] [Related]

  • 8. 5-HT3-receptor antagonists: a review of pharmacology and clinical efficacy.
    Cunningham RS.
    Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):33-40. PubMed ID: 9282379
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19).
    National Cancer Institute of Canada Clinical Trials Group (SC19)National Cancer Institute of Canada Clinical Trials Group, Canada. Rebecca.wong@rmp.uhn.on.ca, Wong RK, Paul N, Ding K, Whitehead M, Brundage M, Fyles A, Wilke D, Nabid A, Fortin A, Wilson D, McKenzie M, Ackerman I, Souhami L, Chabot P, Pater J.
    J Clin Oncol; 2006 Jul 20; 24(21):3458-64. PubMed ID: 16849762
    [Abstract] [Full Text] [Related]

  • 11. The efficacy of 5-HT3 receptor antagonists for the prevention of postoperative nausea and vomiting after craniotomy: a meta-analysis.
    Neufeld SM, Newburn-Cook CV.
    J Neurosurg Anesthesiol; 2007 Jan 20; 19(1):10-7. PubMed ID: 17198095
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
    Hamadani M, Chaudhary L, Awan FT, Khan JK, Kojouri K, Ozer H, Tfayli A.
    J Oncol Pharm Pract; 2007 Jun 20; 13(2):69-75. PubMed ID: 17873106
    [Abstract] [Full Text] [Related]

  • 14. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P, Manusirivithaya S, Tangjitgamol S, Thavaramara T, Sukwattana P.
    J Med Assoc Thai; 2006 Oct 20; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [Abstract] [Full Text] [Related]

  • 15. Parenteral ondansetron for the treatment of chemotherapy- and radiation-induced nausea and vomiting.
    Burnette PK, Perkins J.
    Pharmacotherapy; 1992 Oct 20; 12(2):120-31. PubMed ID: 1533280
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Anti-emetic effect of ondansetron and granisetron after exposure to mixed neutron and gamma irradiation.
    Martin C, Roman V, Agay D, Fatôme M.
    Radiat Res; 1998 Jun 20; 149(6):631-6. PubMed ID: 9611102
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.